Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 16.64
+0.12 (0.73%)
Aug 21, 2026, 5:31 PM CET
SWX:SANN Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SWX:SANN stock has a consensus rating of "Strong Buy" and an average price target of CHF 27.50. The average 1-year stock price forecast is 65.26% higher than the current stock price, while the lowest is CHF 25.00 (+50.24%) and the highest is CHF 30.00 (+80.29%).
Price Target: CHF 27.50 (+65.26%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jul 2, 2026.
Analyst Ratings
The average analyst rating for SWX:SANN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Apr '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates CHF 30.00 | Buy | Reiterates | CHF 30.00 | +80.29% | Jul 2, 2026 |
Financial Forecast
Revenue This Year
94.70M
from 77.19M
Increased by 22.69%
Revenue Next Year
115.55M
from 94.70M
Increased by 22.02%
EPS This Year
-1.21
from -3.78
EPS Next Year
0.17
from -1.21
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.